First quarter 2023 BRIUMVI net sales of $7.8 million
Over 400 BRIUMVI prescriptions in the first partial quarter from 165+ healthcare providers at 125+ centers
Payor coverage in place for over 50% of covered lives for BRIUMVI
Conference call to be held today, Monday, May 1, 2023, at 8:30 AM ET
The Company will host a conference call today, May 1, 2023, at 8:30 AM ET, to discuss the Company’s financial results from the first quarter, ended March 31, 2023, and provide a business outlook for the remainder of 2023.
To participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics. A live audio webcast will be available on the Events page, located within the Investors & Media section, of the Company's website at http://ir.tgtherapeutics.com/events. An audio recording of the conference call will also be available for a period of 30 days after the call.
https://finance.yahoo.com/news/tg-therapeutics-provides-business-reports-113000384.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.